Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lamprecht

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
RMD Open|June 11, 2025
Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 casesEl-Baraa Adjailia, Hanna Grasshoff, Susanne Schinke, et al.
The Lancet. Rheumatology|April 4, 2024
Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitisSamuel D Falde, Lynn A Fussner, Henry D Tazelaar, et al.
Pharmacogenomics|February 20, 2016
Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypesJan Henrik Schirmer, Jan Phillip Bremer, Frank Moosig, et al.
Autoimmunity Reviews|November 14, 2020
Extracorporeal membrane oxygenation in ANCA-associated vasculitisSabrina Arnold, Maria Deja, Martin Nitschke, et al.
Clinical Immunology (Orlando, Fla.)|July 30, 2013
Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis)Juliane Fazio, Elgar Susanne Quabius, Antje Müller, et al.
The American Journal of Pathology|May 10, 2002
Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosisAndras Komocsi, Peter Lamprecht, Elena Csernok, et al.
Blood|February 16, 2006
Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathwayElena Csernok, MaiXing Ai, Wolfgang L Gross, et al.
Trials|August 18, 2021
Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trialNils Venhoff, Wolfgang A Schmidt, Peter Lamprecht, et al.
Journal of Autoimmunity|November 14, 2018
Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitisPeter Lamprecht, Nicole Fischer, Jiabin Huang, et al.
Cellular Immunology|October 24, 2003
Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosisPeter Lamprecht, Ana L Vargas Cuero, Antje Muller, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
RMD Open|June 11, 2025
Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 casesEl-Baraa Adjailia, Hanna Grasshoff, Susanne Schinke, et al.
The Lancet. Rheumatology|April 4, 2024
Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitisSamuel D Falde, Lynn A Fussner, Henry D Tazelaar, et al.
Pharmacogenomics|February 20, 2016
Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypesJan Henrik Schirmer, Jan Phillip Bremer, Frank Moosig, et al.
Autoimmunity Reviews|November 14, 2020
Extracorporeal membrane oxygenation in ANCA-associated vasculitisSabrina Arnold, Maria Deja, Martin Nitschke, et al.
Clinical Immunology (Orlando, Fla.)|July 30, 2013
Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis)Juliane Fazio, Elgar Susanne Quabius, Antje Müller, et al.
The American Journal of Pathology|May 10, 2002
Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosisAndras Komocsi, Peter Lamprecht, Elena Csernok, et al.
Blood|February 16, 2006
Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathwayElena Csernok, MaiXing Ai, Wolfgang L Gross, et al.
Trials|August 18, 2021
Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trialNils Venhoff, Wolfgang A Schmidt, Peter Lamprecht, et al.
Journal of Autoimmunity|November 14, 2018
Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitisPeter Lamprecht, Nicole Fischer, Jiabin Huang, et al.
Cellular Immunology|October 24, 2003
Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosisPeter Lamprecht, Ana L Vargas Cuero, Antje Muller, et al.
Pageof 14